Pharma Co. Must Face Fraud, Trade Secret Claims In Drug Suit
Drug manufacturing company OncoGenerix USA Inc. can't dodge accusations that it ruined a drug developer's shot at $10 million in milestone payments by misrepresenting its ability and willingness to help produce...To view the full article, register now.
Already a subscriber? Click here to view full article